Post-peak mpox in England: epidemiology, reinfection, and vaccine effectiveness – data from 2023
Authors:
Preprint
Abstract
England, like other countries that experienced a large outbreak of emergent mpox in 2022, continued to record cases during 2023 at a low but steady frequency. Comprehensive national surveillance shows that cases continue to occur primarily among gay, bisexual and other men who have sex with men mostly in London. Of 137 cases in 2023, around half were acquired overseas, half were vaccinated, and one case of reinfection was reported. Eleven people required hospital care. High vaccination uptake, during 2022, has provided good coverage of those at higher risk of mpox. Using the screening method, vaccine effectiveness of one dose was estimated at 84%. None of the vaccinated cases in 2023 were hospitalised.Keywords
This publication has 11 references indexed in Scilit:
- Mpox in people with past infection or a complete vaccination course: a global case seriesThe Lancet Infectious Diseases, 2023
- Mpox in People with Past Infection or Complete Vaccination Course: A Global Case SeriesSSRN Electronic Journal, 2023
- O11 Surveillance of Mpox cases attending sexual health services in England (SOMASS): design, implementation and initial findings from the SOMASS data collection tool, 2022Sexually Transmitted Infections, 2023
- COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UKScientific Reports, 2023
- Surveillance of Mpox Cases Attending Sexual Health Services in England (SOMASS): design, implementation and initial findings from the SOMASS data collection tool, 2022Sexually Transmitted Infections, 2023
- Effectiveness of one dose of MVA–BN smallpox vaccine against mpox in England using the case-coverage method: an observational studyThe Lancet Infectious Diseases, 2023
- Case of apparent mpox reinfectionSexually Transmitted Infections, 2023
- Epidemiology of Early Monkeypox Virus Transmission in Sexual Networks of Gay and Bisexual Men, England, 2022Emerging Infectious Diseases, 2022
- Commentary: Estimation of vaccine effectiveness using the screening methodInternational Journal of Epidemiology, 2022
- Risk compensation and vaccination: Can getting vaccinated cause people to engage in risky behaviors?Annals of Behavioral Medicine, 2007